Seeking Funding for Your Medical Device Startup? Take Advantage of this Key Opportunity for Medical Device Entrepreneurs Seeking Funding to Pitch to an Experienced Panel. Email your Presentation by Feb 12 Include Name, Title, Company, and Contact Info MDGPitchFest@mdgboston.org Four medical device startup entrepreneurs will present each company’s value propositions and fundraising efforts to an […]

On January 28th, Boston-based Akcea Therapeutics and Ionis Pharmaceuticals, headquartered in Carlsbad, CA,  announced positive Phase 2 study results of an oligonucleotide treatment of hypertriglyceridemia, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). The oligonucleotide, AKCEA-ANGPTL3-LRx, functions by an antisense-mediated reduction of angiopoietin-like 3 (ANGPTL3) protein in the liver. The antisense oligonucleotide is a […]

Acceleron Pharma has announced that its Phase 2 trial of sotatercept met its primary and key secondary endpoints in patients with pulmonary arterial hypertension (PAH). “We’re thrilled to report such positive topline results…” said Habib Dable, President and Chief Executive Officer of Acceleron. “PAH is a debilitating disease of high unmet medical need, so we’re […]